Axsome Therapeutics, Inc. (AXSM) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2015: $2.63M2016: $16.64M2017: $18.84M2018: $14.44M2019: $41.83M2020: $72.34M2021: $72.15M2022: $221.92M2023: $397.26M2024: $511.48M2025: $601.51M$601.51M
2015Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$601.51M+17.6%
2024$511.48M+28.8%
2023$397.26M+79.0%
2022$221.92M+207.6%
2021$72.15M-0.3%
2020$72.34M+73.0%
2019$41.83M+189.6%
2018$14.44M-23.3%
2017$18.84M+13.2%
2016$16.64M+532.3%
2015$2.63M